Previous Section
Clinical Trials
1. Molecular diagnostics in autosomal dominant polycystic kidney disease: utility and limitations.
- Author
- Zhao X; Paterson AD; Zahirieh A; He N; Wang K; Pei Y;
- Institution
- Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
- Journal
- Clin J Am Soc Nephrol. 2008 Jan;3(1):146-52. Epub 2007 Dec 12.
- Abstract URL
- Click here to view abstract
2. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.
- Author
- Ruggenenti P; Remuzzi A; Ondei P; Fasolini G; Antiga L; Ene-Iordache B; Remuzzi G; Epstein FH;
- Institution
- Nephrology Unit, Azienda Ospedaliera Ospedali Riuniti di Bergamo L. Go Barozzi, Bergamo, Italy.
- Journal
- Kidney Int. 2005 Jul;68(1):206-16.
- Abstract URL
- Click here to view abstract
3. Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD).
- Author
- Cadnapaphornchai, Melissa A; Fick-Brosnahan, Godela M; Duley, Irene; Johnson, Ann M; Strain, John D; DeGroff, Curt G; Schrier, Robert W;
- Institution
- Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado, USA.
- Journal
- Contemp Clin Trials 2005 Apr;26(2):211-22.
- Abstract URL
- Click here to view abstract
Next: Kidney Transplantation
